GEV vs MAR: Which Is the Better Buy?

Side-by-side comparison of GE Vernova Inc. and Marriott International, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
GE Vernova Inc. Β· Industrials
$951.82
+35.4% upside to fair value
Med Conviction Grade B High Quality
VS
Marriott International, Inc. Β· Consumer Cyclical
$334.97
+20.6% upside to fair value
Med Conviction Grade C
QuantHub Verdict
GEV has more upside to fair value (+35.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GEV MAR
Current Price $951.82 $334.97
Fair Value Estimate $1,288.67 $403.81
Upside to Fair Value +35.4% +20.6%
Market Cap $253.5B $87.3B
Forward P/E β€” β€”
EV / EBITDA 28.2x 22.2x
Price / Sales 6.1x 3.2x
Price / FCF 20.5x 28.7x
Revenue Growth YoY +21.9% +4.8%
Gross Margin 20.2% 20.2%
Operating Margin 4.4% 15.8%
Return on Equity 83.4% -66.7%
Dividend Yield 0.18% 0.84%
FCF Yield 4.88% 3.48%
Analyst Consensus Strong Buy Hold
Investment Thesis
GEV β€” GE Vernova Inc.
GE Vernova is an energy equipment and infrastructure enterprise spanning Power (gas, nuclear, hydro, steam), Wind (offshore and onshore turbines), and Electrification (grid, power conversion, solar and storage), with 78,000 employees and a Cambridge, Massachusetts headquarters. The business quality is high on the strength of an installed base that generates roughly 25% of the world's electricity,…
MAR β€” Marriott International, Inc.
Marriott International is a global asset-light hotel franchisor and manager whose 10,082-property, 1.814 million-room system, 629,000-room development pipeline, broad brands, and more than 295 million Bonvoy members support durable fee-led economics. Business quality is tempered by cyclicality, competitive owner incentives, and $16.915 billion of debt, while reported ROE is negative 66.7%. In the…
Accumulation Zones
Metric GEV MAR
Zone Low $966.50 $302.86
Zone High $1,095.37 $343.24
In Buy Zone? Yes Yes
← GEV Research    MAR Research β†’    All Research